Circulatory dysfunction in NAFLD - Which is first, which is last, and what do we do in between?

Hepatology

Volumn 42, Issue 2, 2005, Pages 270-272

  McPherson, David D ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B SCAN; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; EDITORIAL; GLUCOSE METABOLISM; HUMAN; ISCHEMIA; LIPID METABOLISM; LIVER DISEASE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PATIENT MONITORING; PRIORITY JOURNAL; VASODILATATION;

CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FATTY LIVER; HUMANS; LIVER; VASODILATION;

EID: 23044512139     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20834     Document Type: Editorial

References (16)

1. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. HEPATOLOGY 2005;42:473-480.
2. Galle J, Busse R, Bassenge E. Hypercholesterolemia and atherosclerosis change vascular reactivity in rabbits by different mechanisms. Arterioscler Thromb 1991;11:1712-1718.
3. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
4. Badimon L, Badimon JJ, Penny W, Webster MW, Chesebro JH, Fuster V. Endothelium and atherosclerosis. J Hypertension 1992;10(Suppl 2):S43-S50.
5. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-27.
6. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288: 373-376.
7. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
8. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987;61:866-879.
9. Feelisch M, te Poel M, Zamora R, Deussen A, Moncada S. Understanding the controversy over the identiry of EDRF. Nature 1994;368:62-65.
10. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through c-guanosine monophosphate. Circ Res 1983;52:352-357.
11. Lincoln TM. Cyclic GMP and mechanisms of vasodtlation. Pharmacolo Ther 1989;41:479-502.
12. Lefer AM, Ma XL. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to coronary artery endothelium. Atheroscler Thromb 1993;13:771-776.
13. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990;336:897-900.
14. Salmenniemi U, Ruotsalainen E, Pihlajamaki J, Vauhkonen I, Kainulainen S, Punnonen K, et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 2004;110:3842-3848.
15. Gokce N, Vita J, McDonnell M, Forse A, Istfan N, Stoeckl M, et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Circulation 2004;110:111-307.
16. Chalasani N. Statins and hepatotoxicity: Focus on patients with fatty liver. HEPATOLOGY 2005;41:690-695.